GE HealthCare Technologies EBIT 2020-2024 | GEHC
- GE HealthCare Technologies EBIT for the quarter ending September 30, 2024 was $0.675B, a 9.4% increase year-over-year.
- GE HealthCare Technologies EBIT for the twelve months ending September 30, 2024 was $2.511B, a 0.48% decline year-over-year.
- GE HealthCare Technologies 2023 annual EBIT was $2.435B, a 3.45% decline from 2022.
- GE HealthCare Technologies 2022 annual EBIT was $2.522B, a 9.77% decline from 2021.
- GE HealthCare Technologies 2021 annual EBIT was $2.795B, a 2.76% increase from 2020.
GE HealthCare Technologies Annual EBIT (Millions of US $) |
|
---|---|
2023 | $2,435 |
2022 | $2,522 |
2021 | $2,795 |
2020 | $2,720 |
2019 | $2,124 |
GE HealthCare Technologies Quarterly EBIT (Millions of US $) |
|
---|---|
2024-09-30 | $675 |
2024-06-30 | $608 |
2024-03-31 | $539 |
2023-12-31 | $689 |
2023-09-30 | $617 |
2023-06-30 | $570 |
2023-03-31 | $559 |
2022-12-31 | $777 |
2022-09-30 | $605 |
2022-06-30 | $631 |
2022-03-31 | $509 |
2021-12-31 | |
2021-09-30 | |
2020-12-31 | |
2019-12-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $39.264B | $19.552B |
Chicago, IL-based GE Healthcare is a leading maker of medical imaging and patient-monitoring products and related equipment and services. Approximately half of GE Healthcare's revenue comes from equipment sales, with consumables and services accounting for the other half. GE Healthcare started operating as an independent company after its January 2023 spin-off from General Electric (GE). |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $202.220B | 25.79 |
Stryker (SYK) | United States | $143.322B | 32.30 |
Boston Scientific (BSX) | United States | $130.065B | 37.39 |
Medtronic (MDT) | Ireland | $112.498B | 16.74 |
EssilorLuxottica (ESLOY) | France | $111.686B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $45.423B | 0.00 |
Haleon (HLN) | United Kingdom | $43.501B | 28.26 |
ResMed (RMD) | United States | $37.048B | 30.44 |
Terumo (TRUMY) | Japan | $29.575B | 41.77 |
Koninklijke Philips (PHG) | Netherlands | $25.012B | 19.14 |
Zimmer Biomet Holdings (ZBH) | United States | $21.536B | 13.71 |
Insulet (PODD) | United States | $18.791B | 74.86 |
Baxter (BAX) | United States | $17.673B | 11.51 |
Smith & Nephew SNATS (SNN) | United Kingdom | $10.619B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $10.338B | 35.13 |
BellRing Brands (BRBR) | United States | $9.136B | 38.63 |
Demant (WILYY) | Denmark | $8.351B | 0.00 |
Lantheus Holdings (LNTH) | United States | $6.084B | 14.14 |
Haemonetics (HAE) | United States | $4.474B | 21.43 |
TG Therapeutics (TGTX) | United States | $4.460B | 0.00 |
ICU Medical (ICUI) | United States | $4.318B | 41.21 |
Prestige Consumer Healthcare (PBH) | United States | $3.983B | 19.75 |
Perrigo (PRGO) | Ireland | $3.596B | 10.59 |
Neogen (NEOG) | United States | $3.517B | 40.57 |
Envista Holdings (NVST) | United States | $3.509B | 26.14 |
Agios Pharmaceuticals (AGIO) | United States | $3.368B | 0.00 |
GN Store Nord (GNNDY) | Denmark | $3.041B | 19.50 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
QuidelOrtho (QDEL) | United States | $2.942B | 18.94 |
LeMaitre Vascular (LMAT) | United States | $2.342B | 56.97 |
Warby Parker (WRBY) | United States | $1.964B | 0.00 |
Green Thumb Industries (GTBIF) | United States | $1.888B | 33.04 |
AtriCure (ATRC) | United States | $1.826B | 0.00 |
InMode (INMD) | Israel | $1.630B | 9.80 |
Curaleaf Holdings (CURLF) | Canada | $1.384B | 0.00 |
AdaptHealth (AHCO) | United States | $1.357B | 9.70 |
Maravai LifeSciences Holdings (MRVI) | United States | $1.280B | 0.00 |
BioLife Solutions (BLFS) | United States | $1.206B | 0.00 |
Owens & Minor (OMI) | United States | $0.995B | 7.77 |
Phibro Animal Health (PAHC) | United States | $0.966B | 17.04 |
CeriBell (CBLL) | United States | $0.962B | 0.00 |
National Vision Holdings (EYE) | United States | $0.906B | 30.29 |
Capricor Therapeutics (CAPR) | United States | $0.895B | 0.00 |
Evolus (EOLS) | United States | $0.866B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.691B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.605B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.582B | 17.56 |
Quanterix (QTRX) | United States | $0.580B | 0.00 |
Surmodics (SRDX) | United States | $0.549B | 0.00 |
Valneva SE (VALN) | France | $0.426B | 0.00 |
Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
ZimVie (ZIMV) | United States | $0.393B | 33.12 |
Viemed Healthcare (VMD) | United States | $0.353B | 33.59 |
Cerus (CERS) | United States | $0.331B | 0.00 |
OraSure Technologies (OSUR) | United States | $0.320B | 21.45 |
Sanara MedTech (SMTI) | United States | $0.308B | 0.00 |
Biote (BTMD) | United States | $0.301B | 13.90 |
Zynex (ZYXI) | United States | $0.287B | 60.07 |
Jin Medical (ZJYL) | China | $0.284B | 0.00 |
MacroGenics (MGNX) | United States | $0.273B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.269B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.264B | 0.00 |
Omeros (OMER) | United States | $0.256B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.236B | 15.90 |
High Tide (HITI) | Canada | $0.221B | 91.67 |
Brainsway (BWAY) | Israel | $0.181B | 217.20 |
Organigram Holdings (OGI) | Canada | $0.172B | 0.00 |
FitLife Brands (FTLF) | United States | $0.151B | 20.39 |
Rockwell Medical (RMTI) | United States | $0.137B | 0.00 |
TriSalus Life Sciences (TLSI) | United States | $0.129B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.116B | 0.00 |
Zevia PBC (ZVIA) | United States | $0.111B | 0.00 |
Veru (VERU) | United States | $0.107B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.104B | 0.00 |
Fonar (FONR) | United States | $0.095B | 9.82 |
Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 23.10 |
Cellectar Biosciences (CLRB) | United States | $0.086B | 0.00 |
Sanuwave Health (SNWVD) | United States | $0.079B | 2.67 |
Modular Medical (MODD) | United States | $0.072B | 0.00 |
InterCure (INCR) | Israel | $0.070B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.070B | 0.00 |
MariMed (MRMD) | United States | $0.062B | 0.00 |
Safety Shot (SHOT) | United States | $0.062B | 0.00 |
Apyx Medical (APYX) | United States | $0.053B | 0.00 |
Exagen (XGN) | United States | $0.050B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
ImmuCell (ICCC) | United States | $0.028B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Nephros (NEPH) | United States | $0.017B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
GlucoTrack (GCTK) | United States | $0.008B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Agape ATP (ATPC) | $0.006B | 0.00 | |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.004B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
Senestech (SNES) | United States | $0.001B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
United-Guardian (UG) | United States | $0.000B | 14.20 |
SNDL (SNDL) | Canada | $0.000B | 0.00 |